Category: Spotlight Faculty

‘Frankenstein’ proteins offer better control for immunotherapy

Researchers have come up with a tool that offers a means of control over engineered cells, and it comes from a seemingly unlikely source: the hepatitis C genome. In combination with a widely available antiviral medication, the new system offers a novel tool: a highly specific way to turn engineered cells on and off, with an existing, proven medication.